Simian Immunodeficiency Virus
"Simian Immunodeficiency Virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Species of the genus LENTIVIRUS, subgenus primate immunodeficiency viruses (IMMUNODEFICIENCY VIRUSES, PRIMATE), that induces acquired immunodeficiency syndrome in monkeys and apes (SAIDS). The genetic organization of SIV is virtually identical to HIV.
| Descriptor ID |
D015302
|
| MeSH Number(s) |
B04.820.650.589.650.800 B04.820.650.805.700
|
| Concept/Terms |
Simian Immunodeficiency Virus- Simian Immunodeficiency Virus
- Immunodeficiency Virus, Simian
- Simian Immunodeficiency Viruses
- SIV (Simian immunodeficiency virus)
- Immunodeficiency Viruses, Simian
|
Below are MeSH descriptors whose meaning is more general than "Simian Immunodeficiency Virus".
Below are MeSH descriptors whose meaning is more specific than "Simian Immunodeficiency Virus".
This graph shows the total number of publications written about "Simian Immunodeficiency Virus" by people in this website by year, and whether "Simian Immunodeficiency Virus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2009 | 1 | 1 | 2 |
| 2010 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 1 | 2 | 3 |
| 2020 | 1 | 1 | 2 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Simian Immunodeficiency Virus" by people in Profiles.
-
Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model. J Clin Invest. 2022 02 01; 132(3).
-
Antiretroviral therapy does not reduce tuberculosis reactivation in a tuberculosis-HIV coinfection model. J Clin Invest. 2020 10 01; 130(10):5171-5179.
-
Chronic Immune Activation in TB/HIV Co-infection. Trends Microbiol. 2020 08; 28(8):619-632.
-
Mechanisms of reactivation of latent tuberculosis infection due to SIV coinfection. J Clin Invest. 2019 12 02; 129(12):5254-5260.
-
HIV-1 and SIV Infection Are Associated with Early Loss of Lung Interstitial CD4+ T Cells and Dissemination of Pulmonary Tuberculosis. Cell Rep. 2019 02 05; 26(6):1409-1418.e5.
-
CD4 receptor diversity in chimpanzees protects against SIV infection. Proc Natl Acad Sci U S A. 2019 02 19; 116(8):3229-3238.
-
Nonpathologic Infection of Macaques by an Attenuated Mycobacterial Vaccine Is Not Reactivated in the Setting of HIV Co-Infection. Am J Pathol. 2017 Dec; 187(12):2811-2820.
-
CD4+ T-cell-independent mechanisms suppress reactivation of latent tuberculosis in a macaque model of HIV coinfection. Proc Natl Acad Sci U S A. 2016 09 20; 113(38):E5636-44.
-
Destabilization of the gut microbiome marks the end-stage of simian immunodeficiency virus infection in wild chimpanzees. Am J Primatol. 2018 01; 80(1).
-
Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants. J Exp Med. 2014 Nov 17; 211(12):2361-72.